Community/Retail

The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Latest News

GLP-1 dulaglutide (Trulicity) -- Image credit: Edugrafo | stock.adobe.com
Dulaglutide Biosimilar Achieves Equivalent Efficacy in HbA1c Reduction in Patients With T2DM

August 22nd 2025

A new biosimilar, LY05008, shows comparable efficacy and safety to dulaglutide in managing type 2 diabetes mellitus (T2DM) in Chinese adults.

Image credit: IbragimovN | stock.adobe.com
Products News for August 2025

August 22nd 2025

High-density lipoprotein particles(HDL) also known as good cholesterol, in the blood. Higher HDL levels correlate with lower risk of cardiovascular disease
Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence

August 21st 2025

GLP-1 medication bottle with yellow tablets for managing type 2 diabetes and obesity, symbolizing pharmaceutical treatment for blood glucose and weight control - Image credit: Ryan | stock.adobe.com
Orforglipron Shows Positive Efficacy, Tolerability in Weight Management

August 21st 2025

Hand joints inflammation. Concept of rheumatic arthritis, rheumatism, gout, joint swelling or arthralgia - Image credit: ZAY WIN HTAI | stock.adobe.com
FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema

August 21st 2025

More News